𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Safety/tolerability trial of SDZ ENA 713 in patients with probable Alzheimer's disease

✍ Scribed by John J. Sramek; Ravi Anand; Thomas S. Wardle; Peter Irwin; Richard D. Hartman; Neal R. Cutler

Book ID
116019000
Publisher
Elsevier Science
Year
1996
Tongue
English
Weight
560 KB
Volume
58
Category
Article
ISSN
0024-3205

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Safety and tolerability of rivastigmine
Safety and tolerability of rivastigmine capsule with memantine in patients with probable Alzheimer's disease: a 26-week, open-label, prospective trial (Study ENA713B US32)
✍ Jason T. Olin; Vinod Bhatnagar; Patricio Reyes; Barbara Koumaras; Xiangyi Meng; πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 139 KB πŸ‘ 2 views

## Abstract ## Objective Rivastigmine, a dual cholinesterase inhibitor (ChEI), is widely approved for the symptomatic treatment of both mild‐to‐moderate Alzheimer's disease (AD) and Parkinson's disease dementia. Orally administered ChEIs may be associated with gastrointestinal (GI) side effects an